EUVIMEDOpdag EUVIMED
Crossref

In Situ Cross-Linkable Hyaluronic–Ferulic Acid Conjugate Containing Bucladesine Nanoparticles Promotes Neural Regeneration after Spinal Cord Injury

Farzaneh Sorouri, Parastoo Hosseini, Mohammad Sharifzadeh, Sahar Kiani, Mehdi Khoobi iD

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c08366 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2023. Written by Farzaneh Sorouri and 4 co-authors. Institution: Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center (MBRC), Faculty of Pharmacy, Tehran University of Medical Science,…. Major MEDLINE topics: Spinal Cord Injuries, Spinal Cord Regeneration. Cited 18 times so far (Crossref); 70 references. Funded by: National Institute for Medical Research Development, Royan Institute for Stem Cell Biology and Technology, Tehran University of Medical Sciences and Health Services.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Dysfunctional clinical outcomes following spinal cord injury (SCI) result from glial scar formation, leading to the inhibition of new axon growth and impaired regeneration. Nevertheless, nerve regeneration after SCI is possible, provided that the state of neuron development in the injured environment is improved. Hence, biomaterial-based therapy would be a promising strategy to endow a desirable environment for tissue repair. Herein, we designed a novel multifunctional injectable hydrogel with antioxidant, neuroprotective, and neuroregenerative effects. Bucladesine-encapsulated chitosan nanoparticles (BCS NPs) were first prepared and embedded in a matrix of thiol-functionalized hyaluronic acid modified with ferulic acid (HASH-FA). The target hydrogel (HSP-F/BCS) was then created through Michael-type addition between HASH-FA containing BCS NPs and four-arm polyethylene glycol-maleimide (4-Arm-PEG-Mal). The obtained hydrogel with shear thinning behavior showed viscoelastic and mechanical properties similar to the normal nerve tissue. FA conjugation significantly improved the antioxidant activity of HA, and suppressed intracellular ROS formation. In situ injection of the HSP-F/BCS hydrogel in a rat contusion model of SCI inhibited glial scar progression, reduced microglia/macrophage infiltration, promoted angiogenesis, and induced myelinated axon regeneration. As a result, a significant improvement in motor performance was observed compared to other experimental groups. Taken together, the HSP-F/BCS hydrogel developed in this study could be a promising system for SCI repair.

Subjects

MeSH terms (MEDLINE)

Spinal Cord InjuriesSpinal Cord RegenerationAnimalsRatsBucladesineAxonsGliosisAntioxidantsHydrogelsCoumaric Acids

Author keywords

Spinal cord injuryencapsulated bucladesinefunctional recoveryhyaluronic acid−ferulic acid conjugateinjectable hydrogelmyelinated axon regeneration

Substances

BucladesineAntioxidantsHydrogelsferulic acidCoumaric Acids

Authors and institutions

  • Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center (MBRC), Faculty of Pharmacy, Tehran University of Medical Science, Tehran 14176-14411, Iran.
  • Department of Brain and Cognitive Sciences, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16656-59911, Iran.
  • Pharmaceutical Quality Assurance Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran 14176-14411, Iran.
  • Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14176-14411, Iran.
  • Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14176-14411, Iran.

ORCID profiles: Mehdi Khoobi

Funding

  • National Institute for Medical Research Development
  • Royan Institute for Stem Cell Biology and Technology
  • Tehran University of Medical Sciences and Health Services

Cite

APA

Sorouri, F., Hosseini, P., Sharifzadeh, M., Kiani, S., & Khoobi, M. (2023). In Situ Cross-Linkable Hyaluronic–Ferulic Acid Conjugate Containing Bucladesine Nanoparticles Promotes Neural Regeneration after Spinal Cord Injury. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c08366

Vancouver

Sorouri F, Hosseini P, Sharifzadeh M, Kiani S, Khoobi M. In Situ Cross-Linkable Hyaluronic–Ferulic Acid Conjugate Containing Bucladesine Nanoparticles Promotes Neural Regeneration after Spinal Cord Injury. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c08366

BibTeX
@article{Sorouri2023,
  author = {Sorouri, Farzaneh and Hosseini, Parastoo and Sharifzadeh, Mohammad and Kiani, Sahar and Khoobi, Mehdi},
  title = {In Situ Cross-Linkable Hyaluronic–Ferulic Acid Conjugate Containing Bucladesine Nanoparticles Promotes Neural Regeneration after Spinal Cord Injury},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c08366}
}
Start for free →